Reviva Pharmaceuticals (RVPH) Institutional Ownership → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free RVPH Stock Alerts $3.78 -0.12 (-3.08%) (As of 03/28/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$12.05 MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.22 M Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/11/2024Vanguard Group Inc.974,982$5.02M0.0%+58.3%3.492% 2/26/2024Virtu Financial LLC15,234$78K0.0%N/A0.055% 2/15/2024Vanguard Group Inc.974,982$5.02M0.0%+58.3%3.492% 2/13/2024Northern Trust Corp40,224$0.21M0.0%+28.3%0.144% 2/13/2024Tower Research Capital LLC TRC 38,043$0.20M0.0%N/A0.136% 2/13/2024Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023GSA Capital Partners LLP70,181$0.34M0.0%+271.1%0.310% 11/15/2023Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023 EMC Capital Management123,915$0.61M0.4%+1,294.3%0.547% 8/15/2023Wells Fargo & Company MN5,115$30K0.0%+4,550.0%0.025% 8/15/2023Colony Group LLC155,000$0.91M0.0%+66.7%0.758% 8/14/2023Tower Research Capital LLC TRC 11,109$65K0.0%+631.3%0.054% 8/11/2023Renaissance Technologies LLC35,300$0.21M0.0%+84.6%0.173% 8/11/2023BlackRock Inc.90,006$0.53M0.0%+5.9%0.440% 8/11/2023Geode Capital Management LLC150,949$0.89M0.0%+3.8%0.738% 8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023Virtu Financial LLC18,448$0.11M0.0%N/A0.090% 5/16/2023Colony Group LLC93,000$0.39M0.0%N/A0.455% 5/15/2023Two Sigma Investments LP16,400$69K0.0%-65.1%0.080% 2/15/2023Tang Capital Management LLC24,125$0.10M0.0%N/A0.118% 2/14/2023Two Sigma Investments LP47,035$0.20M0.0%N/A0.230% 2/13/2023Charles Schwab Investment Management Inc.12,232$52K0.0%N/A0.060% 2/13/2023Renaissance Technologies LLC20,300$86K0.0%N/A0.099% 2/13/2023Geode Capital Management LLC145,430$0.62M0.0%+86.3%0.711% 2/13/2023 EMC Capital Management123,915$0.53M0.5%+125.0%0.606% 2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/16/2022Jane Street Group LLC17,180$27K0.0%N/A0.084% 11/15/2022Vanguard Group Inc.406,394$0.65M0.0%-12.6%1.988% 11/15/2022BlackRock Inc.83,652$0.13M0.0%N/A0.409% 11/7/2022Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022 Raymond James & Associates33,000$52K0.0%+65.0%0.161% 5/13/2022Renaissance Technologies LLC12,700$31K0.0%N/A0.084% 5/13/2022Vanguard Group Inc.465,508$1.15M0.0%-5.8%3.077% 5/11/2022 Raymond James & Associates14,000$34K0.0%N/A0.093% 2/10/2022 EMC Capital Management55,078$0.16M0.1%-27.4%0.364% 2/3/2022Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$0.14M0.0%+82.7%0.241% 8/17/2021Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021Renaissance Technologies LLC11,250$55K0.0%N/A0.122% Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…8/13/2021Northern Trust Corp10,584$51K0.0%N/A0.115% 8/13/2021Geode Capital Management LLC67,724$0.33M0.0%N/A0.734% 8/13/2021Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108% 5/21/2021Citadel Advisors LLC36,652$0.21M0.0%N/A0.397% 5/18/2021Millennium Management LLC35,310$0.20M0.0%N/A0.382% 5/18/2021Citadel Advisors LLC36,652$0.21M0.0%N/A0.397% 4/28/2021 DAVENPORT & Co LLC15,000$86K0.0%N/A0.162% (Data available from 1/1/2016 forward) RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, 19 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($5.02M), Colony Group LLC ($0.91M), Geode Capital Management LLC ($0.89M), EMC Capital Management ($0.61M), BlackRock Inc. ($0.53M), and GSA Capital Partners LLP ($0.34M).Learn more on RVPH's institutional investors. What percentage of Reviva Pharmaceuticals stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals stock? Of the 19 institutional investors that purchased Reviva Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.16M), Vanguard Group Inc. ($0.72M), EMC Capital Management ($0.18M), Colony Group LLC ($0.16M), BlackRock Inc. ($88.70K), Virtu Financial LLC ($79.80K), and Geode Capital Management LLC ($72.87K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 2,780,421 shares in the last 24 months. This purchase volume represents approximately $13.41M in transactions. Which Reviva Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($0.22M), Vanguard Group Inc. ($87.31K), and Two Sigma Investments LP ($30.64K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 341,949 shares in the last 24 months. This volume of shares sold represents approximately $1.39M in transactions. Related Companies: LTRN Major Shareholders ONCY Major Shareholders ACRS Major Shareholders ELYM Major Shareholders AFMD Major Shareholders BTAI Major Shareholders VERU Major Shareholders ENLV Major Shareholders IFRX Major Shareholders RZLT Major Shareholders This page (NASDAQ:RVPH) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.